Sensitive, high-throughput methods for pharmacokinetic (PK) profiling are essential for potential therapeutics during critical stages of clinical trials. The application of a microfluidic capillary zone electrophoresis mass spectrometry (CZE-MS) method for PK profiling allows for rapid, sensitive and in-depth analysis of multiple samples within a short timeframe. Here, a CZE-MS approach for PK analysis was compared with a traditional UHPLC-MS approach when analyzing serum extracts from rats treated with a potential Alzheimer's disease therapeutic, BNC-1. Resulting PK data generated from both methods displayed statistical similarities. Additionally, the separation efficiency attributed to the use of the CZE-MS method provided substantial metabolic regulation data that was not apparent in the UHPLC-MS method. Additionally, the coupling of the CZE-MS method to the data processing software, MZmine2, was used to monitor changes in metabolism and observe putative BNC-1-derived metabolites. The ability to perform fast analyses without sacrificing sensitivity or metabolic information suggests that this CZE-MS method is ideal for metabolomics-inclusive, high-throughput PK profiling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/bmc.5243 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of monoclonal antibody charge variants under near-native separation conditions using nanoflow sheath liquid capillary electrophoresis-mass spectrometry.
Anal Chim Acta
December 2024
University of Amsterdam, van 't Hoff Institute for Molecular Sciences, Analytical Chemistry Group, Science Park 904, 1098 XH, Amsterdam, the Netherlands; Centre of Analytical Sciences Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands. Electronic address:
Article Synopsis
- Monoclonal antibodies undergo various post-translational modifications that can affect their charge and quality, making it essential to assess these changes to ensure safety in pharmaceuticals.
- A newly developed capillary zone electrophoresis-mass spectrometry (CZE-MS) method allows for effective separation and identification of charge variants in monoclonal antibodies, utilizing a neutral static capillary coating and a volatile background electrolyte.
- This optimized method has shown reliable results in correlating charge variant profiles, enabling better assessment of mAb quality and facilitating the identification of variants that impact their therapeutic effectiveness.
Pilot Study for Deciphering Post-Translational Modifications and Proteoforms of Tau Protein by Capillary Electrophoresis-Mass Spectrometry.
J Proteome Res
November 2024
Department of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, Michigan 48824, United States.
Article Synopsis
- Abnormal tau protein accumulation is a key feature of Alzheimer's disease, with various post-translational modifications (PTMs) such as phosphorylation contributing to the disease's progression.
- A pilot study used complementary techniques, CZE-MS/MS and RPLC-MS/MS, to analyze recombinant human tau-0N3R, resulting in the identification of 50 phosphorylation sites, which is 25% more than RPLC-MS/MS could find alone.
- The study also introduced capillary isoelectric focusing (cIEF)-MS, revealing multiple tau-0N3R proteoforms, some with up to nine phosphorylation sites, highlighting the effectiveness of these techniques for studying tau's complexity and potential dimerization.
Charge variant analysis of monoclonal antibodies by CZE-MS using a successive multiple ionic-polymer layer coating based on diethylaminoethyl-dextran.
Electrophoresis
September 2024
Faculty of Chemistry, Aalen University, Aalen, Germany.
Article Synopsis
- * Traditional CZE methods face challenges linking to mass spectrometry due to incompatible background electrolytes, but a new approach has been developed using a specific cationic coating and acidic background electrolyte to improve separation.
- * The new CZE-ESI-MS method successfully distinguishes between various charge variants of mAbs, including specific forms of USP mAb003 and other antibodies like infliximab and adalimumab, showing its broad applicability in biopharmaceutical analysis.
A simple and efficient approach for preparing cationic coating with tunable electroosmotic flow for capillary zone electrophoresis-mass spectrometry-based top-down proteomics.
Anal Chim Acta
November 2024
Department of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI, 48824, USA. Electronic address:
Article Synopsis
- Capillary zone electrophoresis-tandem mass spectrometry (CZE-MS/MS) is a promising technique for top-down proteomics, but traditional neutral coatings have limitations in separation resolution due to protein adsorption.
- This study introduces a cationic coating using poly (acrylamide-co-(3-acrylamidopropyl) trimethylammonium chloride) [PAMAPTAC], which significantly improves separation resolution and reproducibility for proteoform analysis compared to the standard linear polyacrylamide (LPA) coating.
- The new PAMAPTAC coating enables effective detection of larger proteoforms from complex samples without prior size-based separation, potentially enhancing proteomic studies.
Rapid identification of antibody impurities in size-based electrophoresis via CZE-MS generated spectral library.
Sci Rep
August 2024
Johnson & Johnson Innovative Medicine Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA.
Article Synopsis
- Reliable impurity detection in biopharmaceuticals is key for ensuring product quality and safety; however, traditional methods face technical challenges in accurately identifying individual impurities.
- This study introduces a size-based electrophoresis method combined with mass spectrometry to effectively detect and identify impurities in antibody production from known degradation products.
- By simulating cell culture conditions and forced degradation, the researchers demonstrate that this combined approach improves the detection and identification of impurities, enhancing the development process for antibody therapeutics.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!